DY
VRDN icon

Dowling & Yahnke’s Viridian Therapeutics VRDN Stock Holding History

Dowling & Yahnke’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,666
Closed -$498K – 282
2017
Q1 		$498K Buy
+2,666
New +$498K 0.05% 215